US 11591579
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted A61KA61K2039/505A61K38/45
Quick answer
US patent 11591579 (Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/45, A61K39/395, A61K45/06